• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cytos Biotechnology AG

+ Add to Watchlist

YTS:GR

0.176 EUR 0.026 17.33%

As of 03:16:35 ET on 12/19/2014.

Snapshot for Cytos Biotechnology AG (YTS)

Open: 0.149 Day's Range: 0.118 - 0.176 Volume: 10,000
Previous Close: 0.150 52wk Range: 0.051 - 3.058 1-Yr Rtn: -93.04%

Stock Chart for YTS

No chart data available.
  • YTS:GR 0.176
  • 1D
  • 1M
  • 1Y
0.150
Interactive YTS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for YTS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) -0.9150
Est. PEG Ratio -
Market Cap (M EUR) 5.37
Shares Outstanding (M) 30.53
30 Day Average Volume 4,045
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for YTS

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for YTS

Cytos Biotechnology AG develops and produces biopharmaceuticals. The Company produces vaccines that immunize the patient against disease related proteins. This instructs the immune system to produce antibodies to reverse or prevent disease progression. Cytos develops treatments for immunology and inflammation disorders, cancer and cardiovascular, nervous system, and infectious diseases.

Christian ItinChairman/CEOHarry WeltenExec VP/CFO
Frank HenneckeExec VP:Product DevDorothee KrumwiehVice President
More Company Profile & Key Executives for YTS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil